Christopher Hite

EVP & Chairman, Partnering, Royalty Pharma plc

Bought, 12 months

$0.0M

Sold, 12 months

$27.4M

Companies

Latest trade

Sep 22, 2026

Companies

Royalty Pharma plcEVP & Chairman, Partnering −$27.4M

Trades

RPRX Sold 100,000 shares at $58.53 · planned $5.9M Sep 22

RPRX Sold 100,000 shares at $59.97 · planned $6.0M Aug 18

RPRX Sold 130,000 shares at $56.50 · planned $7.3M Jun 30

RPRX Sold 150,000 shares at $54.39 · planned $8.2M Jun 23

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.